Table 1 Demographic characteristics of week-22 completers
From: d-Cycloserine enhances durability of social skills training in autism spectrum disorder
|  | DCSa (n = 32) | Placebo (n = 28) | p value |
|---|---|---|---|
Characteristics | |||
 Age (years), mean (SDa) | 8.47 (1.83) | 8.07 (1.53) | 0.37 |
 Sex, n (%) male | 26 (81.35) | 23 (82.14) | 1.00 |
 Diagnosis, n (%) autistic disorder | 12 (37.50) | 12 (52.86) | 0.79 |
Concomitant medications, n (%) | |||
 Antipsychotics | 6 (18.75) | 4 (14.29) | 0.74 |
 Alpha-2 agonists | 6 (18.75) | 6 (21.43) | 1.00 |
 Stimulants | 11 (34.38) | 7 (25.00) | 0.57 |
 Antidepressants | 3 (9.38) | 3 (10.72) | 1.00 |
 Atomoxetine | 1 (3.13) | 1 (3.57) | 1.00 |
 Any concomitant medication | 19 (59.39) | 17 (60.71) | 1.00 |
 Mean total concomitant medications | 0.84 | 0.75 | 0.64 |